Age-Related Diabetes — Part 4
Age-Related Diabetes — Part 4
How Does Modern Research Evaluate This Formula?
In the previous parts of this series, we explored how Liuwei Dihuang Wan was designed not to lower blood sugar directly, but to replenish a depleted Yin foundation, regulate internal heat, and restore metabolic balance.
How, then, does modern research evaluate such a formula?
What Clinical Studies Report
A number of clinical studies have suggested that Liuwei Dihuang Wan may influence markers associated with glucose regulation in patients with Type 2 diabetes.
Several studies have reported that when Liuwei Dihuang Wan is added to conventional diabetes medications, improvements in:
- fasting blood glucose
- HbA1c
appear greater than with medication alone (Zhang et al., 2013).
Some studies have also reported changes in HOMA-IR, a commonly used measure of insulin resistance.
Research on Diabetic Complications
Studies have also examined the formula in relation to diabetes-related complications.
In patients with diabetic kidney disease, some reports have observed:
- reductions in proteinuria
- changes in markers of kidney function
(Li et al., 2012)
In diabetic neuropathy, researchers have reported:
- improvements in nerve conduction velocity
- reductions in sensory symptoms
in certain patient populations.
What Mechanism Studies Suggest
Laboratory and animal studies have explored several possible biological pathways.
Reported findings include:
- activation of the PI3K/AKT signaling pathway
- increased antioxidant enzyme activity
- reduction of oxidative stress markers
- protective effects on kidney tissue
(Liu et al., 2015; Wang et al., 2016)
These findings suggest that the formula may influence metabolic and cellular regulatory processes beyond simple glucose control.
But the Limitations Must Also Be Considered
Before accepting these findings at face value, several important limitations should be acknowledged.
1. Study Quality Remains Uneven
Many studies involve:
- relatively small sample sizes
- inconsistent research designs
- limited placebo-controlled trials
- short follow-up periods
(Wang et al., 2016)
As a result, drawing strong clinical conclusions remains difficult.
2. Many Mechanistic Findings Come from Laboratory Models
A significant portion of the pharmacological research comes from:
- cell culture experiments
- animal studies
These findings may provide useful clues, but they do not guarantee the same effects in human clinical practice.
3. The Most Fundamental Limitation
Perhaps the most important limitation lies elsewhere.
Modern research evaluates Liuwei Dihuang Wan using the language of modern medicine:
- HbA1c
- HOMA-IR
- proteinuria
- laboratory biomarkers
These measurements are important.
But they are not necessarily the primary targets of the formula itself.
According to Classical Medicine, the intended goals include:
- restoring a depleted Yin foundation
- regulating internal heat
- rebuilding metabolic balance
The question is not whether these goals exist.
The question is whether current research methodologies can adequately capture them.
This does not mean the formula is effective simply because it claims to be.
Nor does it mean the research is wrong.
Rather, it raises a deeper question:
Are we measuring the same thing that the formula was originally designed to influence?
What Comes Next
In the final part of this series, we will address that question directly.
Where do the perspectives of modern medicine and Classical Medicine diverge?
And what does that difference mean for how we understand age-related diabetes?
댓글
댓글 쓰기